| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription corepressor binding | 7.92e-05 | 59 | 77 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.76e-05 | 188 | 77 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.27e-04 | 85 | 77 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 4.05e-04 | 8 | 77 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 4.05e-04 | 8 | 77 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.88e-04 | 749 | 77 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 6.47e-04 | 10 | 77 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 9.45e-04 | 12 | 77 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 9.45e-04 | 12 | 77 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.11e-03 | 13 | 77 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.30e-03 | 14 | 77 | 2 | GO:0097493 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SETDB1 ASXL1 KAT5 PER2 ERCC6L ATAD2B BCORL1 PER1 EHMT1 KDM3B SENP6 LAMC1 USP15 BAHCC1 | 1.48e-05 | 999 | 76 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | SETDB1 ASXL1 KAT5 PER2 ERCC6L ATAD2B BCORL1 PER1 EHMT1 KDM3B LAMC1 USP15 BAHCC1 | 2.17e-05 | 896 | 76 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | circadian regulation of translation | 8.00e-05 | 4 | 76 | 2 | GO:0097167 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock by photoperiod | 1.04e-04 | 25 | 76 | 3 | GO:0043153 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.33e-04 | 5 | 76 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 1.42e-04 | 135 | 76 | 5 | GO:0042752 | |
| GeneOntologyBiologicalProcess | photoperiodism | 1.47e-04 | 28 | 76 | 3 | GO:0009648 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 1.57e-04 | 138 | 76 | 5 | GO:0030512 | |
| GeneOntologyBiologicalProcess | regulation of lipopolysaccharide-mediated signaling pathway | 1.82e-04 | 30 | 76 | 3 | GO:0031664 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock | 1.82e-04 | 30 | 76 | 3 | GO:0009649 | |
| MousePheno | abnormal ocular fundus morphology | DDIT4 IQSEC3 THBS4 FBN2 SASH1 PER2 GUCY1A1 FAT3 BACH2 TMCC2 BCORL1 PEPD BBS1 LAMC1 PCARE EML1 MFRP CNGA1 LDLR MEIS1 | 7.93e-07 | 1262 | 66 | 20 | MP:0002864 |
| MousePheno | abnormal retina morphology | DDIT4 IQSEC3 THBS4 SASH1 PER2 GUCY1A1 FAT3 TMCC2 BCORL1 PEPD BBS1 LAMC1 PCARE EML1 MFRP CNGA1 LDLR MEIS1 | 9.81e-06 | 1227 | 66 | 18 | MP:0001325 |
| MousePheno | abnormal circadian sleep/wake cycle | 2.15e-05 | 12 | 66 | 3 | MP:0020478 | |
| MousePheno | abnormal photoreceptor outer segment morphology | 5.23e-05 | 141 | 66 | 6 | MP:0003729 | |
| MousePheno | abnormal circulating unsaturated transferrin level | 1.08e-04 | 20 | 66 | 3 | MP:0011895 | |
| MousePheno | abnormal circulating transferrin level | 1.45e-04 | 22 | 66 | 3 | MP:0011892 | |
| MousePheno | abnormal retina neuronal layer morphology | 2.14e-04 | 441 | 66 | 9 | MP:0006069 | |
| MousePheno | abnormal sleep pattern | 2.33e-04 | 64 | 66 | 4 | MP:0001501 | |
| MousePheno | shortened circadian behavior period | 2.42e-04 | 26 | 66 | 3 | MP:0020470 | |
| MousePheno | photoreceptor outer segment degeneration | 2.71e-04 | 27 | 66 | 3 | MP:0008584 | |
| MousePheno | decreased a-wave amplitude | 2.78e-04 | 67 | 66 | 4 | MP:0012143 | |
| MousePheno | abnormal photoreceptor inner segment morphology | 2.94e-04 | 68 | 66 | 4 | MP:0003730 | |
| MousePheno | abnormal a-wave amplitude | 3.11e-04 | 69 | 66 | 4 | MP:0012030 | |
| MousePheno | abnormal a-wave shape | 3.29e-04 | 70 | 66 | 4 | MP:0012034 | |
| MousePheno | abnormal retina photoreceptor morphology | 4.15e-04 | 206 | 66 | 6 | MP:0001004 | |
| MousePheno | increased memory-marker CD4-negative NK T cell number | 4.54e-04 | 7 | 66 | 2 | MP:0013514 | |
| MousePheno | abnormal retina photoreceptor layer morphology | 5.20e-04 | 215 | 66 | 6 | MP:0003728 | |
| MousePheno | abnormal retina layer morphology | 5.69e-04 | 504 | 66 | 9 | MP:0003727 | |
| MousePheno | decreased skeletal muscle size | 5.74e-04 | 81 | 66 | 4 | MP:0010240 | |
| MousePheno | decreased b-wave amplitude | 6.01e-04 | 82 | 66 | 4 | MP:0012144 | |
| MousePheno | abnormal circadian behavior period | 6.42e-04 | 36 | 66 | 3 | MP:0020468 | |
| MousePheno | retina cone cell degeneration | 6.42e-04 | 36 | 66 | 3 | MP:0008444 | |
| MousePheno | disorganized photoreceptor outer segment | 6.42e-04 | 36 | 66 | 3 | MP:0008586 | |
| MousePheno | abnormal circadian behavior | 6.59e-04 | 84 | 66 | 4 | MP:0020467 | |
| MousePheno | abnormal skeletal muscle mass | 6.82e-04 | 149 | 66 | 5 | MP:0004817 | |
| MousePheno | abnormal b-wave shape | 6.89e-04 | 85 | 66 | 4 | MP:0012035 | |
| MousePheno | abnormal b-wave amplitude | 6.89e-04 | 85 | 66 | 4 | MP:0012031 | |
| MousePheno | abnormal eye vasculature morphology | 7.18e-04 | 415 | 66 | 8 | MP:0031346 | |
| MousePheno | retina degeneration | 7.52e-04 | 87 | 66 | 4 | MP:0001326 | |
| MousePheno | arrhythmic circadian behavior persistence | 7.74e-04 | 9 | 66 | 2 | MP:0020472 | |
| MousePheno | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | 7.74e-04 | 9 | 66 | 2 | MP:0013430 | |
| MousePheno | increased memory-marker NK cell number | 7.74e-04 | 9 | 66 | 2 | MP:0013427 | |
| MousePheno | abnormal somatic nervous system morphology | ZNF106 FBN2 CLCA1 GUCY1A1 FAT3 BACH2 PEPD BBS1 PCARE EML1 MFRP CNGA1 LDLR | 8.72e-04 | 1025 | 66 | 13 | MP:0002752 |
| Domain | EGF_Ca-bd_CS | 1.39e-10 | 97 | 73 | 9 | IPR018097 | |
| Domain | EGF_CA | 1.67e-10 | 99 | 73 | 9 | PS01187 | |
| Domain | EGF_CA | 1.10e-09 | 122 | 73 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.27e-09 | 124 | 73 | 9 | IPR001881 | |
| Domain | EGF_CA | 1.53e-09 | 86 | 73 | 8 | PF07645 | |
| Domain | EGF-like_dom | SLIT2 THBS3 THBS4 FBN2 MALRD1 HMCN2 FAT3 LRP1 LAMC1 CUBN LDLR | 3.26e-09 | 249 | 73 | 11 | IPR000742 |
| Domain | EGF_1 | SLIT2 THBS3 THBS4 FBN2 MALRD1 HMCN2 FAT3 LRP1 LAMC1 CUBN LDLR | 4.18e-09 | 255 | 73 | 11 | PS00022 |
| Domain | EGF-like_CS | SLIT2 THBS3 THBS4 FBN2 MALRD1 HMCN2 FAT3 LRP1 LAMC1 CUBN LDLR | 5.32e-09 | 261 | 73 | 11 | IPR013032 |
| Domain | EGF_2 | SLIT2 THBS3 THBS4 FBN2 MALRD1 HMCN2 FAT3 LRP1 LAMC1 CUBN LDLR | 6.24e-09 | 265 | 73 | 11 | PS01186 |
| Domain | Growth_fac_rcpt_ | 9.65e-09 | 156 | 73 | 9 | IPR009030 | |
| Domain | EGF_3 | 2.55e-08 | 235 | 73 | 10 | PS50026 | |
| Domain | EGF | 2.55e-08 | 235 | 73 | 10 | SM00181 | |
| Domain | Period_circadian-like_C | 5.73e-08 | 3 | 73 | 3 | IPR022728 | |
| Domain | Period_C | 5.73e-08 | 3 | 73 | 3 | PF12114 | |
| Domain | ASX_HYDROXYL | 1.24e-07 | 100 | 73 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.86e-07 | 106 | 73 | 7 | IPR000152 | |
| Domain | LDLR_class-A_CS | 1.76e-05 | 40 | 73 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 2.83e-05 | 45 | 73 | 4 | PF00057 | |
| Domain | - | 3.10e-05 | 46 | 73 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.67e-05 | 48 | 73 | 4 | PS01209 | |
| Domain | LDLRA_2 | 3.98e-05 | 49 | 73 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.98e-05 | 49 | 73 | 4 | IPR002172 | |
| Domain | LDLa | 3.98e-05 | 49 | 73 | 4 | SM00192 | |
| Domain | Thbs/COMP_coiled-coil | 4.51e-05 | 3 | 73 | 2 | IPR024665 | |
| Domain | COMP | 4.51e-05 | 3 | 73 | 2 | PF11598 | |
| Domain | Laminin_G | 7.77e-05 | 58 | 73 | 4 | IPR001791 | |
| Domain | PAS_fold_3 | 9.59e-05 | 23 | 73 | 3 | IPR013655 | |
| Domain | PAS_3 | 9.59e-05 | 23 | 73 | 3 | PF08447 | |
| Domain | PAS-assoc_C | 1.09e-04 | 24 | 73 | 3 | IPR000700 | |
| Domain | EGF | 1.34e-04 | 126 | 73 | 5 | PF00008 | |
| Domain | PAC | 1.40e-04 | 26 | 73 | 3 | IPR001610 | |
| Domain | PAC | 1.40e-04 | 26 | 73 | 3 | SM00086 | |
| Domain | PAC | 1.40e-04 | 26 | 73 | 3 | PS50113 | |
| Domain | TSP_3 | 1.50e-04 | 5 | 73 | 2 | PF02412 | |
| Domain | PKNOX/Meis_N | 1.50e-04 | 5 | 73 | 2 | IPR032453 | |
| Domain | TSP3 | 1.50e-04 | 5 | 73 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.50e-04 | 5 | 73 | 2 | PS51236 | |
| Domain | - | 1.50e-04 | 5 | 73 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.50e-04 | 5 | 73 | 2 | IPR008859 | |
| Domain | TSP_C | 1.50e-04 | 5 | 73 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.50e-04 | 5 | 73 | 2 | IPR017897 | |
| Domain | Meis_PKNOX_N | 1.50e-04 | 5 | 73 | 2 | PF16493 | |
| Domain | Thrombospondin_3-like_rpt | 1.50e-04 | 5 | 73 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 1.50e-04 | 5 | 73 | 2 | IPR028974 | |
| Domain | PAS | 2.62e-04 | 32 | 73 | 3 | SM00091 | |
| Domain | PreSET | 3.12e-04 | 7 | 73 | 2 | SM00468 | |
| Domain | Pre-SET | 3.12e-04 | 7 | 73 | 2 | PF05033 | |
| Domain | Pre-SET_dom | 3.12e-04 | 7 | 73 | 2 | IPR007728 | |
| Domain | PRE_SET | 3.12e-04 | 7 | 73 | 2 | PS50867 | |
| Domain | PAS | 3.14e-04 | 34 | 73 | 3 | IPR000014 | |
| Domain | PAS | 3.14e-04 | 34 | 73 | 3 | PS50112 | |
| Domain | - | 5.23e-04 | 95 | 73 | 4 | 2.60.120.200 | |
| Domain | Ldl_recept_b | 1.33e-03 | 14 | 73 | 2 | PF00058 | |
| Domain | LDLRB | 1.33e-03 | 14 | 73 | 2 | PS51120 | |
| Domain | LY | 1.53e-03 | 15 | 73 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.53e-03 | 15 | 73 | 2 | IPR000033 | |
| Domain | ConA-like_dom | 1.67e-03 | 219 | 73 | 5 | IPR013320 | |
| Domain | Sec7 | 1.75e-03 | 16 | 73 | 2 | SM00222 | |
| Domain | SEC7 | 1.75e-03 | 16 | 73 | 2 | PS50190 | |
| Domain | Sec7_dom | 1.75e-03 | 16 | 73 | 2 | IPR000904 | |
| Domain | Homeobox_KN | 1.97e-03 | 17 | 73 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 1.97e-03 | 17 | 73 | 2 | IPR008422 | |
| Domain | TSPN | 3.61e-03 | 23 | 73 | 2 | SM00210 | |
| Domain | cEGF | 4.61e-03 | 26 | 73 | 2 | IPR026823 | |
| Domain | cEGF | 4.61e-03 | 26 | 73 | 2 | PF12662 | |
| Domain | hEGF | 5.33e-03 | 28 | 73 | 2 | PF12661 | |
| Pathway | WP_MELATONIN_METABOLISM_AND_EFFECTS | 1.24e-05 | 37 | 55 | 4 | M39418 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 1.56e-05 | 13 | 55 | 3 | M18009 | |
| Pubmed | Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects. | 1.09e-08 | 3 | 78 | 3 | 19013183 | |
| Pubmed | A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. | 1.09e-08 | 3 | 78 | 3 | 9428527 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 26781276 | ||
| Pubmed | Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. | 1.09e-08 | 3 | 78 | 3 | 9427249 | |
| Pubmed | Association between polymorphisms in period genes and bone density in postmenopausal Korean women. | 1.09e-08 | 3 | 78 | 3 | 24678593 | |
| Pubmed | Photic entrainment of period mutant mice is predicted from their phase response curves. | 1.09e-08 | 3 | 78 | 3 | 20826680 | |
| Pubmed | Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. | 1.09e-08 | 3 | 78 | 3 | 11395012 | |
| Pubmed | mPeriod2 Brdm1 and other single Period mutant mice have normal food anticipatory activity. | 1.09e-08 | 3 | 78 | 3 | 29138421 | |
| Pubmed | A time memory engram embedded in a light-entrainable circadian clock. | 1.09e-08 | 3 | 78 | 3 | 37951213 | |
| Pubmed | Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. | 1.09e-08 | 3 | 78 | 3 | 12032351 | |
| Pubmed | Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. | 1.09e-08 | 3 | 78 | 3 | 15790588 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 22331899 | ||
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 25550826 | ||
| Pubmed | A light-independent oscillatory gene mPer3 in mouse SCN and OVLT. | 1.09e-08 | 3 | 78 | 3 | 9707434 | |
| Pubmed | Intracellular calcium mobilization induces period genes via MAP kinase pathways in NIH3T3 cells. | 1.09e-08 | 3 | 78 | 3 | 11959112 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 32805476 | ||
| Pubmed | Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. | 1.09e-08 | 3 | 78 | 3 | 15031135 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 11591712 | ||
| Pubmed | Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s). | 1.09e-08 | 3 | 78 | 3 | 22891330 | |
| Pubmed | The role of phosphorylation and degradation of hPER protein oscillation in normal human fibroblasts. | 1.09e-08 | 3 | 78 | 3 | 14712925 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 32849922 | ||
| Pubmed | Circadian clock regulates hepatic polyploidy by modulating Mkp1-Erk1/2 signaling pathway. | 1.09e-08 | 3 | 78 | 3 | 29269828 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 23869717 | ||
| Pubmed | SLIT2 SETDB1 TUT4 FBN2 KAT5 HMCN2 FAT3 BACH2 PER1 LRP1 EHMT1 C11orf16 LDLR AKAP8L BAHCC1 | 2.36e-08 | 1116 | 78 | 15 | 31753913 | |
| Pubmed | An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. | 4.33e-08 | 4 | 78 | 3 | 11232563 | |
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 9856466 | ||
| Pubmed | Endotoxin Disrupts Circadian Rhythms in Macrophages via Reactive Oxygen Species. | 4.33e-08 | 4 | 78 | 3 | 27168152 | |
| Pubmed | Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. | 4.33e-08 | 4 | 78 | 3 | 15800623 | |
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 10487202 | ||
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 10899319 | ||
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 19587447 | ||
| Pubmed | Expression of basic helix-loop-helix/PAS genes in the mouse suprachiasmatic nucleus. | 4.33e-08 | 4 | 78 | 3 | 10077321 | |
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 22217103 | ||
| Pubmed | Identification of a conserved family of Meis1-related homeobox genes. | 4.33e-08 | 4 | 78 | 3 | 9049632 | |
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 10508692 | ||
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 9856465 | ||
| Pubmed | Disturbance of circadian gene expression in hepatocellular carcinoma. | 1.08e-07 | 5 | 78 | 3 | 18444243 | |
| Pubmed | Intercellular coupling confers robustness against mutations in the SCN circadian clock network. | 1.08e-07 | 5 | 78 | 3 | 17482552 | |
| Pubmed | 1.08e-07 | 5 | 78 | 3 | 11865049 | ||
| Pubmed | Dimerization and nuclear entry of mPER proteins in mammalian cells. | 1.08e-07 | 5 | 78 | 3 | 10837028 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NHSL1 PLEKHG1 TLNRD1 DACT1 SYNRG PER2 TMCC2 PER1 EHMT1 KDM3B ICE1 LDLR REXO1 BAHCC1 | 1.52e-07 | 1105 | 78 | 14 | 35748872 |
| Pubmed | A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. | 2.16e-07 | 6 | 78 | 3 | 9989497 | |
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 9988221 | ||
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 28886335 | ||
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 21411511 | ||
| Pubmed | The role of polymorphisms in circadian pathway genes in breast tumorigenesis. | 2.16e-07 | 6 | 78 | 3 | 20978934 | |
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 14750904 | ||
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 20829506 | ||
| Pubmed | mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. | 2.16e-07 | 6 | 78 | 3 | 10428031 | |
| Pubmed | PLEKHH1 ARFGEF3 PLEKHG1 SETDB1 ASXL1 IQSEC3 TCF20 PER2 USP15 | 3.37e-07 | 407 | 78 | 9 | 12693553 | |
| Pubmed | 3.77e-07 | 7 | 78 | 3 | 23546644 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARFGEF3 NHSL1 PLEKHG1 SYNRG ZNF106 MTMR4 TCF20 SASH1 ERCC6L KDM3B LAMC1 CARD8 | 4.77e-07 | 861 | 78 | 12 | 36931259 |
| Pubmed | ZNF106 SETDB1 RIOK1 MTMR4 TUT4 TCF20 ERCC6L KDM3B SRPRA ICE1 USP15 | 7.30e-07 | 733 | 78 | 11 | 34672954 | |
| Pubmed | 9.03e-07 | 9 | 78 | 3 | 14701732 | ||
| Pubmed | Decapping Enzyme NUDT12 Partners with BLMH for Cytoplasmic Surveillance of NAD-Capped RNAs. | 9.03e-07 | 9 | 78 | 3 | 31875550 | |
| Pubmed | Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. | 1.29e-06 | 10 | 78 | 3 | 16528748 | |
| Pubmed | Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. | 1.29e-06 | 10 | 78 | 3 | 19934327 | |
| Pubmed | Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. | 4.84e-06 | 15 | 78 | 3 | 12024206 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34275001 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 28710114 | ||
| Pubmed | Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. | 4.97e-06 | 2 | 78 | 2 | 19273907 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23977055 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22236088 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22238756 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21793695 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27021954 | ||
| Pubmed | Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. | 4.97e-06 | 2 | 78 | 2 | 24551282 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21459569 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17505534 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17889283 | ||
| Pubmed | Constant darkness is a circadian metabolic signal in mammals. | 4.97e-06 | 2 | 78 | 2 | 16421573 | |
| Pubmed | Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. | 4.97e-06 | 2 | 78 | 2 | 11389837 | |
| Pubmed | Circadian regulation of central ethanol sensitivity by the mPer2 gene. | 4.97e-06 | 2 | 78 | 2 | 19523042 | |
| Pubmed | Cocaine sensitization and reward are under the influence of circadian genes and rhythm. | 4.97e-06 | 2 | 78 | 2 | 12084940 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11207804 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15009158 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35475497 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20370466 | ||
| Pubmed | cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. | 4.97e-06 | 2 | 78 | 2 | 18487196 | |
| Pubmed | 174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy. | 4.97e-06 | 2 | 78 | 2 | 21810984 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35810166 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23110090 | ||
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 4.97e-06 | 2 | 78 | 2 | 11971949 | |
| Pubmed | Circadian Modulation of Neurons and Astrocytes Controls Synaptic Plasticity in Hippocampal Area CA1. | 4.97e-06 | 2 | 78 | 2 | 33053337 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 33393850 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24603368 | ||
| Pubmed | The circadian clock protects against ionizing radiation-induced cardiotoxicity. | 4.97e-06 | 2 | 78 | 2 | 31919902 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12775559 | ||
| Pubmed | Circadian time-dependent tumor suppressor function of period genes. | 4.97e-06 | 2 | 78 | 2 | 19926612 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17996461 | ||
| Pubmed | Circadian gene expression is resilient to large fluctuations in overall transcription rates. | 4.97e-06 | 2 | 78 | 2 | 19078963 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 16581003 | ||
| Pubmed | The circadian clock and tumor suppression by mammalian period genes. | 4.97e-06 | 2 | 78 | 2 | 15817328 | |
| Pubmed | Low reproductive success in Per1 and Per2 mutant mouse females due to accelerated ageing? | 4.97e-06 | 2 | 78 | 2 | 18367514 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21773940 | ||
| Pubmed | Homeostatic sleep regulation is preserved in mPer1 and mPer2 mutant mice. | 4.97e-06 | 2 | 78 | 2 | 12383239 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19477955 | ||
| Pubmed | Mice lacking Period 1 and Period 2 circadian clock genes exhibit blue cone photoreceptor defects. | 4.97e-06 | 2 | 78 | 2 | 23351077 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23285241 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34160105 | ||
| Interaction | PER3 interactions | 1.87e-06 | 24 | 76 | 4 | int:PER3 | |
| Interaction | COL20A1 interactions | 3.07e-06 | 27 | 76 | 4 | int:COL20A1 | |
| Cytoband | 11p15.3 | 5.86e-04 | 21 | 78 | 2 | 11p15.3 | |
| Cytoband | 10p12.31 | 6.44e-04 | 22 | 78 | 2 | 10p12.31 | |
| Cytoband | 6q23.3 | 1.05e-03 | 28 | 78 | 2 | 6q23.3 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 4.81e-07 | 26 | 45 | 4 | 526 | |
| GeneFamily | Low density lipoprotein receptors | 4.64e-04 | 13 | 45 | 2 | 634 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.23e-03 | 34 | 45 | 2 | 487 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.30e-05 | 191 | 78 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.66e-05 | 196 | 78 | 6 | M3008 | |
| Coexpression | GSE13306_TREG_VS_TCONV_SPLEEN_UP | 2.98e-05 | 200 | 78 | 6 | M3224 | |
| Coexpression | GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN | 2.98e-05 | 200 | 78 | 6 | M9067 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLIT2 SETDB1 ASXL1 TUT4 SASH1 ATAD2B ARHGAP12 KDM3B LAMC1 USP15 LDLR | 4.47e-05 | 856 | 78 | 11 | M4500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 4.85e-07 | 82 | 76 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 7.61e-07 | 207 | 76 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.79e-06 | 354 | 76 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 5.00e-06 | 122 | 76 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 5.73e-06 | 33 | 76 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.40e-05 | 146 | 76 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.40e-05 | 146 | 76 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.50e-05 | 310 | 76 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.81e-05 | 418 | 76 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.04e-05 | 156 | 76 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.73e-05 | 337 | 76 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.80e-05 | 165 | 76 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 4.03e-05 | 356 | 76 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 4.18e-05 | 54 | 76 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.57e-05 | 265 | 76 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 4.72e-05 | 364 | 76 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.85e-05 | 182 | 76 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 5.81e-05 | 188 | 76 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 5.94e-05 | 59 | 76 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.63e-05 | 125 | 76 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | SLIT2 DACT1 TUT4 FBN2 CLCA1 ERCC6L GUCY1A1 FAT3 LRP1 CNGA1 MEIS1 | 8.66e-05 | 768 | 76 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.04e-04 | 130 | 76 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | PLEKHG1 SETDB1 MTMR4 TUT4 PER3 FAT3 PER1 BBS1 ZNF770 EML1 AKAP8L MEIS1 CARD8 BAHCC1 | 1.19e-04 | 1245 | 76 | 14 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 1.30e-04 | 421 | 76 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.34e-04 | 423 | 76 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | SLIT2 DACT1 FBN2 CLCA1 CSRNP3 ERCC6L GUCY1A1 FAT3 LRP1 CNGA1 MEIS1 | 1.66e-04 | 827 | 76 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.67e-04 | 437 | 76 | 8 | GSM777046_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 1.77e-04 | 78 | 76 | 4 | ratio_EB_vs_SC_500_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 3.10e-04 | 361 | 76 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 3.14e-04 | 37 | 76 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.43e-04 | 168 | 76 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 4.13e-04 | 175 | 76 | 5 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 4.58e-04 | 42 | 76 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 4.58e-04 | 42 | 76 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | DACT1 SETDB1 THBS4 CLCA1 FOXQ1 GUCY1A1 FAT3 BACH2 INSR LAMC1 | 5.81e-04 | 806 | 76 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 6.42e-04 | 408 | 76 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 7.36e-04 | 831 | 76 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_100 | 8.15e-04 | 12 | 76 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k1_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.70e-04 | 311 | 76 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.85e-04 | 312 | 76 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 7.88e-07 | 181 | 78 | 6 | 61608123959483ff60f07d8467996853c4371b6a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-07 | 182 | 78 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-06 | 196 | 78 | 6 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.25e-06 | 196 | 78 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 78 | 6 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 199 | 78 | 6 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 171 | 78 | 5 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 1.26e-05 | 171 | 78 | 5 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 175 | 78 | 5 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-05 | 179 | 78 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 180 | 78 | 5 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 1.80e-05 | 184 | 78 | 5 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 1.84e-05 | 185 | 78 | 5 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.94e-05 | 187 | 78 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.94e-05 | 187 | 78 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 1.94e-05 | 187 | 78 | 5 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.99e-05 | 188 | 78 | 5 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 1.99e-05 | 188 | 78 | 5 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.04e-05 | 189 | 78 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-05 | 189 | 78 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.04e-05 | 189 | 78 | 5 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 2.10e-05 | 190 | 78 | 5 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 2.15e-05 | 191 | 78 | 5 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 2.15e-05 | 191 | 78 | 5 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 192 | 78 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 2.20e-05 | 192 | 78 | 5 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-05 | 192 | 78 | 5 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-05 | 192 | 78 | 5 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 192 | 78 | 5 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 193 | 78 | 5 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 193 | 78 | 5 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 193 | 78 | 5 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 2.26e-05 | 193 | 78 | 5 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.26e-05 | 193 | 78 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-05 | 193 | 78 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.26e-05 | 193 | 78 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 193 | 78 | 5 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.26e-05 | 193 | 78 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.37e-05 | 195 | 78 | 5 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.37e-05 | 195 | 78 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.37e-05 | 195 | 78 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.37e-05 | 195 | 78 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 195 | 78 | 5 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.37e-05 | 195 | 78 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 196 | 78 | 5 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 196 | 78 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.49e-05 | 197 | 78 | 5 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.49e-05 | 197 | 78 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 198 | 78 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.55e-05 | 198 | 78 | 5 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 198 | 78 | 5 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 198 | 78 | 5 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-05 | 199 | 78 | 5 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-05 | 199 | 78 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-05 | 199 | 78 | 5 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.61e-05 | 199 | 78 | 5 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.68e-05 | 200 | 78 | 5 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-05 | 200 | 78 | 5 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 2.68e-05 | 200 | 78 | 5 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 2.68e-05 | 200 | 78 | 5 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 141 | 78 | 4 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.75e-04 | 159 | 78 | 4 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 163 | 78 | 4 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 163 | 78 | 4 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-04 | 165 | 78 | 4 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 2.01e-04 | 165 | 78 | 4 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 166 | 78 | 4 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 166 | 78 | 4 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 166 | 78 | 4 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-04 | 166 | 78 | 4 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 2.11e-04 | 167 | 78 | 4 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 2.11e-04 | 167 | 78 | 4 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 168 | 78 | 4 | 2c996d09b6a8ccd3c708146eca310b02eafff425 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 169 | 78 | 4 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 169 | 78 | 4 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 169 | 78 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 172 | 78 | 4 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-04 | 172 | 78 | 4 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.41e-04 | 173 | 78 | 4 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-04 | 173 | 78 | 4 | 34357f0e22c4b6d84582492c82c1ea733ca8477d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-04 | 176 | 78 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 176 | 78 | 4 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-04 | 176 | 78 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 176 | 78 | 4 | d09e28606e2a6ed1f660898316765ca215085c18 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 176 | 78 | 4 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.81e-04 | 180 | 78 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-04 | 180 | 78 | 4 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 181 | 78 | 4 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 181 | 78 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.87e-04 | 181 | 78 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 181 | 78 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.87e-04 | 181 | 78 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 181 | 78 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.93e-04 | 182 | 78 | 4 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 2.93e-04 | 182 | 78 | 4 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 182 | 78 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | 3.35e-07 | 199 | 76 | 8 | 454_UP | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; PC3; HT_HG-U133A | 4.03e-06 | 195 | 76 | 7 | 4003_UP | |
| Drug | Orlistat, 5 | 1.02e-05 | 86 | 76 | 5 | CID000004599 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 2.82e-09 | 8 | 76 | 4 | DOID:0050425 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 1.53e-07 | 19 | 76 | 4 | DOID:1240 (implicated_via_orthology) | |
| Disease | cortical thickness | NHSL1 PLEKHG1 SLIT2 DACT1 ZNF106 THBS3 FBN2 MALRD1 FAT3 ARHGAP12 LRP1 LAMC1 EML1 USP15 | 8.43e-07 | 1113 | 76 | 14 | EFO_0004840 |
| Disease | Myeloid Leukemia, Chronic | 9.19e-07 | 29 | 76 | 4 | C0023473 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.45e-06 | 335 | 76 | 8 | EFO_0009931 | |
| Disease | mean arterial pressure | 5.49e-06 | 499 | 76 | 9 | EFO_0006340 | |
| Disease | mean arterial pressure, alcohol drinking | 5.59e-06 | 98 | 76 | 5 | EFO_0004329, EFO_0006340 | |
| Disease | Beta blocking agent use measurement | 1.17e-05 | 114 | 76 | 5 | EFO_0009929 | |
| Disease | diastolic blood pressure, alcohol drinking | 1.38e-05 | 118 | 76 | 5 | EFO_0004329, EFO_0006336 | |
| Disease | Calcium channel blocker use measurement | 1.89e-05 | 213 | 76 | 6 | EFO_0009930 | |
| Disease | Advanced Sleep-Phase Syndrome, Familial | 1.96e-05 | 3 | 76 | 2 | C1858496 | |
| Disease | systolic blood pressure, alcohol drinking | 2.05e-05 | 128 | 76 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | cardiovascular disease | 2.34e-05 | 457 | 76 | 8 | EFO_0000319 | |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 3.92e-05 | 4 | 76 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | pulse pressure measurement | PLEKHG1 FBN2 MALRD1 GUCY1A1 FAT3 ATAD2B ARHGAP12 INSR PEPD LRP1 EML1 SRFBP1 MEIS1 | 5.17e-05 | 1392 | 76 | 13 | EFO_0005763 |
| Disease | smoking status measurement, systolic blood pressure | 5.29e-05 | 156 | 76 | 5 | EFO_0006335, EFO_0006527 | |
| Disease | smoking status measurement, diastolic blood pressure | 5.79e-05 | 159 | 76 | 5 | EFO_0006336, EFO_0006527 | |
| Disease | Diuretic use measurement | 7.73e-05 | 169 | 76 | 5 | EFO_0009928 | |
| Disease | colorectal cancer, hormone replacement therapy | 8.04e-05 | 88 | 76 | 4 | EFO_0003961, MONDO_0005575 | |
| Disease | brain measurement, neuroimaging measurement | 8.59e-05 | 550 | 76 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | neuroimaging measurement | NHSL1 PLEKHG1 SLIT2 DACT1 ZNF106 FBN2 FAT3 ARHGAP12 LAMC1 EML1 BAHCC1 | 8.90e-05 | 1069 | 76 | 11 | EFO_0004346 |
| Disease | breast cancer (is_marker_for) | 1.18e-04 | 185 | 76 | 5 | DOID:1612 (is_marker_for) | |
| Disease | spontaneous preterm birth | 1.37e-04 | 101 | 76 | 4 | EFO_0006917 | |
| Disease | myocardial infarction | 2.90e-04 | 350 | 76 | 6 | EFO_0000612 | |
| Disease | mean arterial pressure, alcohol consumption measurement | 3.31e-04 | 52 | 76 | 3 | EFO_0006340, EFO_0007878 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 3.71e-04 | 54 | 76 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | essential hypertension, age at diagnosis | 4.13e-04 | 56 | 76 | 3 | EFO_0004918, MONDO_0001134 | |
| Disease | Withdrawal Symptoms | 4.58e-04 | 58 | 76 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 4.58e-04 | 58 | 76 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 4.58e-04 | 58 | 76 | 3 | C0038587 | |
| Disease | brain connectivity measurement | 5.88e-04 | 400 | 76 | 6 | EFO_0005210 | |
| Disease | cortical surface area measurement | NHSL1 PLEKHG1 SLIT2 DACT1 ZNF106 FBN2 FAT3 ATAD2B ARHGAP12 LAMC1 EML1 | 6.38e-04 | 1345 | 76 | 11 | EFO_0010736 |
| Disease | Abnormal behavior | 7.67e-04 | 16 | 76 | 2 | C0233514 | |
| Disease | coronary artery disease | PLEKHG1 FBN2 MALRD1 R3HCC1L GUCY1A1 LRP1 LAMC1 EML1 SRFBP1 LDLR | 9.57e-04 | 1194 | 76 | 10 | EFO_0001645 |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.19e-03 | 307 | 76 | 5 | EFO_0004612, EFO_0020946 | |
| Disease | nose morphology measurement, mouth morphology measurement | 1.33e-03 | 21 | 76 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | Malignant neoplasm of breast | 1.74e-03 | 1074 | 76 | 9 | C0006142 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 2.04e-03 | 26 | 76 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | hypertension, COVID-19 | 2.20e-03 | 27 | 76 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | cholesteryl ester 14:0 measurement | 2.20e-03 | 27 | 76 | 2 | EFO_0010340 | |
| Disease | Colorectal Carcinoma | 2.21e-03 | 702 | 76 | 7 | C0009402 | |
| Disease | Disorder of eye | 2.22e-03 | 212 | 76 | 4 | C0015397 | |
| Disease | obsolete_red blood cell distribution width | 2.34e-03 | 1347 | 76 | 10 | EFO_0005192 | |
| Disease | anterior thigh muscle fat infiltration measurement | 2.37e-03 | 28 | 76 | 2 | EFO_0020936 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.41e-03 | 103 | 76 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | Retinitis Pigmentosa | 2.48e-03 | 104 | 76 | 3 | C0035334 | |
| Disease | hormone measurement, thyroid stimulating hormone measurement | 2.54e-03 | 29 | 76 | 2 | EFO_0004730, EFO_0004748 | |
| Disease | Bilateral Wilms Tumor | 2.54e-03 | 29 | 76 | 2 | C2930471 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CNGGAAADSDSSLDE | 451 | P08588 | |
| CEQSYGTNSSDESGS | 581 | Q9BYV9 | |
| ASQEAGSGYDSEDCE | 1646 | Q9P281 | |
| EESTTGDCQHFGSQE | 36 | Q5H9F3 | |
| CGSNEASTVSGENDV | 111 | Q8IXJ9 | |
| DSCSGDSSAQLSSGE | 1411 | O94823 | |
| CSDNSDSDNDEGTEG | 296 | Q9ULX6 | |
| GNDTEDFSNPSACSD | 431 | Q7Z5L2 | |
| NTDSGSVCREASFDG | 151 | P12955 | |
| VAGGDVCSSESFNED | 106 | O00470 | |
| GFANCADGSDETNCS | 281 | Q9BY79 | |
| ADGSDETNCSAKFSG | 286 | Q9BY79 | |
| DSGDYECQATNEVGS | 1316 | Q8NDA2 | |
| GDNDCGNSEDESNAT | 916 | Q07954 | |
| NCLNGEASTDSFEGI | 1266 | Q9ULI0 | |
| NCLGTDEDSQDSSDG | 191 | Q92993 | |
| EEDGSSFCSGVTDSS | 346 | Q8WYN3 | |
| ETNAAGSSSEACDFL | 1326 | Q5SYE7 | |
| CEEAQGGAKASSSQD | 1251 | O15534 | |
| NCSTGRDSQGSDCDD | 46 | O15055 | |
| NEDSADGAATSCGQV | 1181 | P56645 | |
| SFGCSSAQEAQKDTD | 506 | Q7LBC6 | |
| GGDVCSSDSFNEDIA | 96 | Q99687 | |
| NVTEFDGQDACGSNS | 541 | P06213 | |
| EDSCAEAAASGAADG | 551 | Q9UPP2 | |
| SLSTGNNDTSEACDA | 271 | Q9NYA4 | |
| TSFSQEQSCDSAGEG | 191 | Q8IWW6 | |
| GGDVCSSDSFNEDNT | 96 | A8K0S8 | |
| DNCGDNTDENECGSS | 1506 | Q5VYJ5 | |
| DSENANLAGTFCGST | 3226 | O60494 | |
| SEAFSCSEGSEQQDA | 1111 | Q9Y2F5 | |
| TNCFGDSESSVSEGE | 751 | Q9NYF0 | |
| SSDCESLDSSNSGFG | 51 | Q9NX09 | |
| DFGNQGSTVESLCDD | 191 | Q5TH69 | |
| GTSSSDVSANCGFDD | 4511 | Q8TDW7 | |
| EQESSEGQDSGDICS | 121 | Q9Y2G2 | |
| VCSSSDTGLFTNDEG | 226 | Q9NWQ4 | |
| TGGDEQQALCTDEFS | 196 | P11047 | |
| SNGGTNLCAVDDSND | 336 | O00423 | |
| NEGFQSSSSGTECLD | 2366 | P35556 | |
| SSDSDACGAESNEAN | 6 | Q8NFJ9 | |
| SSLGFESESGESEGC | 301 | D6RIA3 | |
| DGETNGSCENSDASS | 51 | Q9H9B1 | |
| AEQGDDEFTDVCNSG | 71 | Q2NKX8 | |
| GDDSLGSDGDCAANS | 36 | Q9C009 | |
| CSEDSGIGADNESVQ | 346 | A6NGG8 | |
| RGGDVCSSDSFNEDN | 11 | A6NDR6 | |
| IGSSECSDTDSEEQG | 501 | Q9BRS2 | |
| DNVDGHSSSEDAGAC | 1191 | Q8N1G1 | |
| DDECSSASASSAGAG | 476 | O75069 | |
| GASQETPNECSDDFG | 1011 | Q9UMZ2 | |
| NNESEVSLCESSGSG | 361 | Q5FBB7 | |
| SCNSVSEGGFADSDS | 986 | Q15047 | |
| NNSGNEDCAEFSGSG | 361 | Q9H2X3 | |
| TDGEDNTISGCFNEV | 411 | A8K7I4 | |
| ENGACSSFSEDDDSA | 31 | P29973 | |
| SSSSSSCEQDGVEND | 336 | Q9NQ32 | |
| VGDSCDTNQDSDGDG | 621 | P35443 | |
| QEDSNSDGVGDICES | 691 | P35443 | |
| SSLSGNSDGGEEFCE | 241 | Q8NEF9 | |
| SNDFSNDDGVDEGIC | 451 | Q96K76 | |
| GDNDSENGLCTEDTC | 686 | Q9Y4E8 | |
| ASSGAGAESFEQCRD | 66 | Q9H1K6 | |
| FDGSSNCNSREQSDD | 236 | O94885 | |
| DGFLADDNCSSEIGQ | 946 | Q9GZR1 | |
| SGGQLQDLDCSSSDD | 286 | P08240 | |
| AIQDFTCDDGNDDNS | 706 | O94813 | |
| VSQSDAFEGSDFSCA | 556 | Q04864 | |
| DAEETANQTCGGTDS | 241 | A6NIE6 | |
| AESLDGGCSSSSEDQ | 516 | Q9UGU0 | |
| DQQNSDTDSFGDACD | 526 | P49746 | |
| CDTNEDSDGDGHQDT | 621 | P49746 | |
| ESSGSDDDCSSQASF | 491 | Q9ULM0 | |
| TDNGTTCNDFASSGD | 166 | Q9BXA5 | |
| SICGSSGEEFFNNCE | 441 | Q6IQ21 | |
| FVDADFSDNVCSGNT | 1306 | Q9ULL1 | |
| QTCTDNTGDSDDSAS | 216 | Q5TAX3 | |
| QESNGEGNCLSSSAS | 971 | Q9H2Y7 | |
| AATDSSCTSGAEQND | 996 | Q9H2Y7 | |
| GNGNNFESREACEES | 421 | Q8TEU8 | |
| PNESSEEAAGSSESC | 26 | Q02108 | |
| CDGSAECQDGSDESQ | 46 | P01130 |